Zacks analyst Grant Zeng was out pounding the table on Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG), reiterating an Outperform rating and a $10.
Zacks analyst Grant Zeng was out pounding the table on Arrowhead Research Corp. (NASDAQ:ARWR), reiterating an Outperform rating and a $15 price target, which represents a …
